Human CD4+ T cells spontaneously detect somatic mutations in cancer cells

CD4+ helper T cells are immune cells that can specifically target cancer cells, but the antigens they recognize on tumor cells are mostly unknown. A new study shows that CD4+ T cells recognize peptides encoded by mutated genes in human melanoma, opening the way for new approaches to cancer immunotherapy.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Figure 1: Identification of human CD4+ T cells that recognize neoepitopes.

Marina Corral Spence/Nature Publishing Group


  1. 1

    Rosenberg, S.A. Nat. Rev. Clin. Oncol. 11, 630–632 (2014).

  2. 2

    Linnemann, C. et al. Nat. Med. 2, 81–85 (2015).

  3. 3

    Robbins, P.F. et al. Nat. Med. 19, 747–752 (2013).

  4. 4

    Snyder, A. et al. N. Engl. J. Med. 371, 2189–2199 (2014).

  5. 5

    Kim, H.J. & Cantor, H. Cancer Immunol. Res. 2, 91–98 (2014).

  6. 6

    Hunder, N.N. et al. N. Engl. J. Med. 358, 2698–2703 (2008).

  7. 7

    Tran, E. et al. Science 344, 641–645 (2014).

  8. 8

    Hailemichael, Y. et al. Nat. Med. 19, 465–472 (2013).

  9. 9

    Cobbold, M. et al. Sci. Transl. Med. 5, 203ra125 (2013).

Download references

Author information

Correspondence to Willem W Overwijk.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Overwijk, W. Human CD4+ T cells spontaneously detect somatic mutations in cancer cells. Nat Med 21, 12–14 (2015) doi:10.1038/nm.3783

Download citation

Further reading